ProfileGDS4718 / 227476_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 84% 82% 89% 78% 85% 84% 83% 83% 77% 79% 85% 82% 77% 84% 82% 83% 76% 82% 86% 80% 83% 85% 80% 79% 85% 87% 86% 87% 79% 90% 91% 85% 88% 82% 93% 93% 83% 81% 82% 89% 78% 84% 81% 82% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.2941984
GSM549102patient 115, normal, homogenized [OPG study]8.0820882
GSM549104patient 119, normal, homogenized [OPG study]9.0318989
GSM549108patient 138, normal, homogenized [OPG study]7.5712478
GSM549119patient 077, normal, homogenized [OPG study]8.3709885
GSM549133patient 032, cancer, homogenized [OPG study]8.5036384
GSM549139patient 042, cancer, homogenized [OPG study]8.2644783
GSM549099patient 107, normal, homogenized [OPG study]8.1593883
GSM549109patient 139, normal, homogenized [OPG study]7.5207677
GSM549110patient 046, normal, homogenized [OPG study]7.7466879
GSM549114patient 063, normal, homogenized [OPG study]8.5892585
GSM549122patient 082, normal, homogenized [OPG study]8.0979182
GSM549134patient 033, cancer, homogenized [OPG study]7.554177
GSM549136patient 036, cancer, homogenized [OPG study]8.455784
GSM549140patient 044, cancer, homogenized [OPG study]8.1593782
GSM549111patient 047, normal, homogenized [OPG study]8.250283
GSM549113patient 057, normal, homogenized [OPG study]7.5311876
GSM549132patient 031, cancer, homogenized [OPG study]8.1032182
GSM549137patient 038, cancer, homogenized [OPG study]8.5675686
GSM549142patient 047, cancer, homogenized [OPG study]7.6006280
GSM549100patient 110, normal, homogenized [OPG study]8.1614983
GSM549107patient 135, normal, homogenized [OPG study]8.4518285
GSM549115patient 068, normal, homogenized [OPG study]7.9634980
GSM549116patient 072, normal, homogenized [OPG study]7.7503979
GSM549120patient 078, normal, homogenized [OPG study]8.4139585
GSM549131patient 030, cancer, homogenized [OPG study]8.7856887
GSM549118patient 074, normal, homogenized [OPG study]8.6027886
GSM549129patient 027, cancer, homogenized [OPG study]8.6175887
GSM549123patient 088, normal, homogenized [OPG study]7.8017779
GSM549124patient 006, cancer, homogenized [OPG study]8.9748590
GSM549126patient 015, cancer, homogenized [OPG study]9.2751891
GSM549128patient 025, cancer, homogenized [OPG study]8.4959785
GSM549103patient 117, normal, homogenized [OPG study]8.7402788
GSM549117patient 073, normal, homogenized [OPG study]8.0866782
GSM549138patient 041, cancer, homogenized [OPG study]9.8252293
GSM549141patient 045, cancer, homogenized [OPG study]9.8212993
GSM549130patient 028, cancer, homogenized [OPG study]8.1651383
GSM549101patient 111, normal, homogenized [OPG study]7.9767781
GSM549105patient 128, normal, homogenized [OPG study]7.9966282
GSM549106patient 134, normal, homogenized [OPG study]9.1739489
GSM549112patient 048, normal, homogenized [OPG study]7.6317978
GSM549125patient 011, cancer, homogenized [OPG study]8.2262784
GSM549127patient 024, cancer, homogenized [OPG study]7.9688281
GSM549135patient 035, cancer, homogenized [OPG study]8.196782